Pharmacists empowered with VISIBILITY: DISCOVER TRACEABILITY

LEARN MORE

AN IMMEDIATE SOLUTION FOR EU FMD COMPLIANCE

LEARN MORE

OPTEL CONDUCTING PILOT PROJECT WITH OXFORD UNIVERSITY HOSPITALS TO IMPLEMENT CERTA DECOMMISSIONING SOLUTION FOR FMD COMPLIANCE

OPTEL GROUP, a leading global provider of traceability systems for the pharmaceutical, medical device, and healthcare industries, announced today that it has signed an agreement to pilot OPTEL’s Certa decommissioning solution at Oxford University Hospitals (OUH) to enable the world-renowned institution to comply with the European Union’s Falsified Medicines Directive (FMD).

LEARN MORE

OPTEL LAUNCHES VERIFICATION AND DECOMMISSIONING SOLUTIONS FOR HOSPITAL AND RETAIL PHARMACIES

OPTEL GROUP, a leading global provider of traceability systems for the pharmaceutical and medical device industries, announced that it has extended its expertise to include solutions for the healthcare industry, namely for hospital and retail pharmacies.

For more information, please consult our Latest News section below.

LEARN MORE

DATA-DRIVEN SOLUTIONS FOR HOSPITALS AND PHARMACIES

VERIFICATION

Verifying the status of healthcare products with the NMVS ─ providing unfailing and instantaneous notification of any non-conformities.

DECOMMISSIONING

Deactivating product identifiers once medication is dispensed – ensuring patient safety through data status modification.

RECOMMISSIONING

Reactivating product identifiers on time – helping create a more sustainable healthcare system by reducing waste and increasing overall patient care.

EXPLORE OUR EXPERTISE SECTION. SEE HOW THE FMD AFFECTS PHARMACY OPERATIONS

COMPLETE. CLEAR. CONCISE.

LEARN MORE

Latest News

Optel Certa

OPTEL CONDUCTING PILOT PROJECT WITH OXFORD UNIVERSITY HOSPITALS

OPTEL GROUP, a leading global provider of traceability systems for the pharmaceutical, medical device, and healthcare industries, announced today that it has signed an agreement to pilot OPTEL’s Certa decommissioning solution at Oxford University Hospitals (OUH) to enable the world-renowned institution to comply with the European Union’s Falsified Medicines Directive (FMD).

Optel Group

OPTEL ACQUIRES VERIFY BRAND

OPTEL GROUP, a leading global provider of traceability systems for the pharmaceutical and medical device industries, announced today that it is expanding its traceability offering through the acquisition of Verify Brand.

Verification device

OPTEL LAUNCHES VERIFICATION AND DECOMMISSIONING SOLUTIONS FOR HOSPITAL AND RETAIL PHARMACIES

OPTEL GROUP, a leading global provider of traceability systems for the pharmaceutical and medical device industries, announced today that it has extended its
expertise to include solutions for the healthcare industry, namely for hospital and retail pharmacies.

FDA

FDA Delays Serialization Enforcement to Avoid Supply Distorsions

On June 30, the FDA announced that it is now allowing additional time for pharmaceutical manufacturers to comply with product identifier requirements.

All news

Upcoming Events

May
29

Paris Healthcare Week

Paris, France - Porte de Versailles

All events